OTC Markets EXMKT - Delayed Quote USD
Neutra Corp. (NTRR)
At close: October 21 at 4:00 PM EDT
Breakdown
TTM
1/31/2024
1/31/2023
1/31/2022
1/31/2021
1/31/2020
Total Revenue
66.0670
39.5340
67.9960
92.0140
9.6870
--
Cost of Revenue
23.5810
25.1990
32.6900
60.8530
42.9440
--
Gross Profit
42.4860
14.3350
35.3060
31.1610
-33.2570
--
Operating Expense
216.2490
243.8210
332.9810
614.7430
445.4080
--
Operating Income
-173.7630
-229.4860
-297.6750
-583.5820
-478.6650
--
Net Non Operating Interest Income Expense
-4.0080
-3.3400
-62.0630
-60.6060
-121.6480
--
Other Income Expense
--
--
-198.1560
11.2620
61.4210
39.3250
Pretax Income
-177.7710
-232.8260
-557.8940
-632.9260
-538.8920
--
Tax Provision
0.0500
0.6390
3.5230
--
--
--
Net Income Common Stockholders
-177.8210
-233.4650
-576.8620
-742.1880
-580.6920
--
Diluted NI Available to Com Stockholders
-177.8210
-233.4650
-576.8620
-742.1880
-580.6920
--
Basic EPS
-0.00
-0.00
-0.00
-0.00
-0.00
--
Diluted EPS
-0.00
-0.00
-0.00
-0.00
-0.00
--
Basic Average Shares
2,917,945.4660
2,916,066.0650
2,230,594.1120
1,599,716.6160
1,192,972.5930
--
Diluted Average Shares
2,917,945.4660
2,916,066.0650
2,230,594.1120
1,599,716.6160
1,192,972.5930
--
Total Operating Income as Reported
-173.7630
-229.4860
-297.6750
-583.5820
-478.6650
--
Total Expenses
239.8300
269.0200
365.6710
675.5960
488.3520
--
Net Income from Continuing & Discontinued Operation
-177.8210
-233.4650
-561.4170
-632.9260
-538.8920
--
Normalized Income
-177.8210
-233.4650
-561.4170
-644.1880
-538.8920
--
Interest Expense
4.0080
3.3400
62.0630
60.6060
121.6480
--
Net Interest Income
-4.0080
-3.3400
-62.0630
-60.6060
-121.6480
--
EBIT
-173.7630
-229.4860
-495.8310
-572.3200
-417.2440
--
EBITDA
-144.1290
-181.2470
-416.9250
-494.5350
-386.5780
--
Reconciled Cost of Revenue
23.5810
25.1990
32.6900
60.8530
42.9440
--
Reconciled Depreciation
29.6340
48.2390
78.9060
77.7850
30.6660
--
Net Income from Continuing Operation Net Minority Interest
-177.8210
-233.4650
-561.4170
-632.9260
-538.8920
--
Total Unusual Items Excluding Goodwill
--
--
--
11.2620
61.4210
39.3250
Total Unusual Items
--
--
--
11.2620
61.4210
39.3250
Normalized EBITDA
-144.1290
-181.2470
-416.9250
-505.7970
-386.5780
--
Tax Rate for Calcs
0.0002
0.0002
0.0002
--
--
--
1/31/2020 - 10/12/2011
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
HESG Health Sciences Group, Inc.
0.0000
0.00%
MCET MultiCell Technologies, Inc.
0.0000
0.00%
PSYBF PsyBio Therapeutics Corp.
0.0050
0.00%
CDTTW Conduit Pharmaceuticals Inc.
0.0149
0.00%
ENDV Endonovo Therapeutics, Inc.
0.0009
0.00%
TXTM ProText Mobility, Inc.
0.0018
+5.88%
AAGH America Great Health
0.0012
0.00%
RSPI RespireRx Pharmaceuticals Inc.
0.0013
0.00%
NKGNW NKGen Biotech, Inc.
0.0320
+10.34%
GSTC GlobeStar Therapeutics Corporation
0.0004
0.00%